American Heart Journal
Volume 157, Issue 3 , Pages 412-422 , March 2009

Facts and controversies of aspirin and clopidogrel therapy

  • David P. Faxon, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
    • Corresponding Author InformationReprint requests: David P. Faxon, MD, Harvard Medical School, Brigham & Women's Hospital, Department of Medicine, 0BC3 – Room 012P, 1620 Tremont Street, Boston, MA 02120.
    • ,
  • Jane E. Freedman, MD

      Affiliations

    • Division of Cardiology, Boston University School of Medicine, Boston, MA

Received 25 April 2008 ,Accepted 25 November 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-8703(08)01042-9

doi: 10.1016/j.ahj.2008.11.019

American Heart Journal
Volume 157, Issue 3 , Pages 412-422 , March 2009

Article Tools

* Image Usage & Resolution